3SBio Inc. (HKG:1530)

Hong Kong · Delayed Price · Currency is HKD

23.90

0.00 (0.00%)

At close: Feb 23, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Development, Production, Marketing and Sale of Biopharmaceutical Products	9.11B	7.82B	6.87B	6.38B	5.59B
Development, Production, Marketing and Sale of Biopharmaceutical Products Growth	16.53%	13.84%	7.58%	14.22%	5.07%
Total	9.11B	7.82B	6.87B	6.38B	5.59B
Total Growth	16.53%	13.84%	7.58%	14.22%	5.07%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Mainland China	8.85B	7.60B	6.66B	6.24B	5.42B
Mainland China Growth	16.48%	14.14%	6.67%	15.13%	4.74%
Others	257.28M	217.43M	208.75M	141.09M	166.70M
Others Growth	18.33%	4.16%	47.96%	-15.36%	16.98%
Total	9.11B	7.82B	6.87B	6.38B	5.59B
Total Growth	16.53%	13.84%	7.58%	14.22%	5.07%

Source: S&P Global Market Intelligence.